{"id":4936,"date":"2025-10-27T10:13:01","date_gmt":"2025-10-27T07:13:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4936"},"modified":"2025-10-30T13:22:59","modified_gmt":"2025-10-30T10:22:59","slug":"avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/es\/avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis\/","title":{"rendered":"Novartis adquirir\u00e1 Avidity Biosciences."},"content":{"rendered":"<p class=\"wp-block-paragraph\">Avidity Biosciences, que est\u00e1 desarrollando una terapia de omisi\u00f3n del ex\u00f3n 44 para la distrofia muscular de Duchenne, anunci\u00f3 que ha firmado un acuerdo de fusi\u00f3n definitivo con Novartis AG (\u201cNovartis\u201d) que ha sido aprobado por unanimidad por los Consejos de Administraci\u00f3n de ambas compa\u00f1\u00edas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La adquisici\u00f3n se producir\u00e1 tras la separaci\u00f3n de los programas iniciales de cardiolog\u00eda de precisi\u00f3n de Avidity en SpinCo, que se espera que cotice en bolsa. SpinCo estar\u00e1 dirigida por Kathleen Gallagher, actual directora de programas de Avidity, como directora ejecutiva. Sarah Boyce, actual directora ejecutiva de Avidity, presidir\u00e1 el consejo de administraci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Novartis adquirir\u00e1 los programas y la cartera de productos de Avidity en neurociencia y obtendr\u00e1 acceso a su plataforma de administraci\u00f3n dirigida por ARN diferenciada. El acuerdo incluye tres programas de desarrollo cl\u00ednico en fase avanzada: delpacibart zotadirsen (del-zota) para el tratamiento de la distrofia muscular de Duchenne (DMD), delpacibart etedesiran (del-desiran) para el tratamiento de la distrofia miot\u00f3nica tipo 1 (DM1) y delpacibart braxlosiran (del-brax) para el tratamiento de la distrofia muscular facioescapulohumeral (FSHD).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>M\u00e1s informaci\u00f3n<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/es\/del-zota-dmd-rna-therapy-from-avidity-biosciences-reverses-the-progression-of-disease\/\">La terapia con ARN DMD Del-Zota a partir de Avidity Biosciences revierte la progresi\u00f3n de la enfermedad<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Avidity Biosciences, which is developing an exon 44 skipping therapy for Duchenne muscular dystrophy, announced that it has entered into a definitive merger agreement with Novartis AG (&#8220;Novartis&#8221;) which has been unanimously approved by the Boards of Directors of both companies. The acquisition will follow the separation of Avidity&#8217;s early-stage precision cardiology programs into SpinCo, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4938,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[126,141,127,246,447],"class_list":["post-4936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-avidity-biosciences","tag-exon-44","tag-exon-44-skipping","tag-exon-44-skipping-therapies","tag-novartis"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/4936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=4936"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/4936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/4938"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=4936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=4936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=4936"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}